ReviewDrugs2026

Reframing the High-density Lipoprotein (HDL) Hypothesis in Light of Clinical Trials of Cholesterol Ester Transfer Protein (CETP) Inhibitors.

Michael J Chehade et al.PubMed ↗Publisher ↗

No numbers read from the abstract.